U.S. Supplemental Health Market (By Product: Critical Illness Insurance, Accident Insurance, Hospital Indemnity Insurance, Worksite Life, Dental; By Distribution Channel: Direct-to-Consumer, Agents, Brokers, Others; By Demography: Individuals Aged 65 and Above, Individuals Aged Below 65 with an Eligible Disability) - Analysis, Size, Share, Growth, Trends, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on U.S. Supplemental Health Market
5.1. COVID-19 Landscape: U.S. Supplemental Health Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. U.S. Supplemental Health Market, By Product
8.1. U.S. Supplemental Health Market, by Product, 2023-2032
8.1.1 Critical Illness Insurance
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Accident Insurance
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Hospital Indemnity Insurance
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Worksite Life
8.1.4.1. Market Revenue and Forecast (2020-2032)
8.1.5. Dental
8.1.5.1. Market Revenue and Forecast (2020-2032)
Chapter 9. U.S. Supplemental Health Market, By Distribution Channel
9.1. U.S. Supplemental Health Market, by Distribution Channel, 2023-2032
9.1.1. Direct-to-Consumer (DTC)
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Agents
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. Brokers
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. U.S. Supplemental Health Market, By Demography
10.1. U.S. Supplemental Health Market, by Demography, 2023-2032
10.1.1. Individuals Aged 65 and Above
10.1.1.1. Market Revenue and Forecast (2020-2032)
10.1.2. Individuals Aged Below 65 with an Eligible Disability
10.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 11. U.S. Supplemental Health Market, country Estimates and Trends Forecast
11.1. U.S.
11.1.1. Market Revenue and Forecast, by Product (2020-2032)
11.1.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
11.1.3. Market Revenue and Forecast, by Demography (2020-2032)
Chapter 12. Company Profiles
12.1. Aetna Inc.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Allianz S.E.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. American International Group, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Anthem, Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Assurant, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. AXA Group
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Cigna Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Humana Inc.
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. MetLife, Inc.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Zurich Insurance Group AG
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client